FDA approves subcutaneous Leqembi for treatment of early Alzheimer’s disease

September 2, 2025

The U.S. Food and Drug Administration has approved Leqembi Iqlik, a subcutaneous version of lecanemab, for weekly maintenance after the 18-month intravenous (IV) phase.

New HIV vaccine design trains immune system to hit shared viral target across variants
Researchers at Karolinska Institutet, in collaboration with colleagues at The Scripps Research Institute and Emory University, have developed a new vaccine strategy that has generated antibodies capable of neutralizing highly divergent HIV variants. The study, published in the journal Nature, provides new insights into how the immune system can be guided towards a particularly protected part of the virus.
Infants make nuanced moral character judgments as early as 12 months old
Psychologists at the University of Toronto have found that we begin to make moral character judgments as early as 12 months old. The research, published in Communications Psychology, also recognizes that individuals can exist along a moral spectrum and suggests that early social interactions may play a role in shaping infants' moral judgments.
Nerves in skin can slow melanoma growth
Nerve fibers within melanomas can slow their growth, according to a study led by Weill Cornell Medicine investigators. The findings help clarify the emerging field of cancer neuroscience and may inform future therapeutic strategies.
Methamphetamine use linked to 1 in 6 heart attacks in California study
Methamphetamine (meth) use accounted for nearly 15% of heart attacks for a decade in a northern California study, published today in JAHA.
Validation study reveals new tool can predict patients' genetic risk of 8 cardiovascular conditions
Researchers at Mass General Brigham Heart and Vascular Institute and collaborators have developed and validated a new genetic risk test that can estimate a person's inherited risk for eight common cardiovascular conditions, offering a more comprehensive approach to prevention.

FDA approves subcutaneous Leqembi for treatment of early Alzheimer’s disease

Recent Posts

JUST IN